Keywords: majority, patients, discontinued, use, cox-2, inhibitors, nearly

Majority of US patients have discontinued use of COX-2 inhibitors

Article | 11 April 2005

Print This

Nearly two-thirds of US patients who were taking a COX-2 inhibitor prior to the recall of Merck & Co's Vioxx (rofecoxib) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in